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A B S T R A C T
Propylparaben, a commonly used antimicrobial preservative, has been reported as an anticonvulsant agent
targeting neuronal Na+ channels (NaV). However, the specific features of the NaV channel inhibition by this
agent have so far not been extensively studied. Moreover, it is still unclear if it shares this pharmacological
activity with other parabens. Here, we fully characterized the mechanism of action of the inhibitory effect that
propylparaben and benzylparaben induce on human NaV 1.2 channel isoform (hNaV1.2). We established a first
approach to know the parabens structural determinants for this channel inhibition. The parabens effects on
hNaV1.2 channel mediated currents were recorded using the patch-clamp whole-cell configuration on hNaV1.2
stably transfected HEK293 cells. Propylparaben induced a typical state-dependent inhibition on hNaV1.2 channel
carried current, characterized by a left-shift in the steady-state inactivation curve, a prolongation in the time
needed for recovery from fast inactivation and a frequency-dependent blocking behavior. The state-dependent
inhibition is increased for butylparaben and benzylparaben and diminished for methylparaben, ethylparaben
and p-hydroxybenzoic acid (the major metabolite of parabens hydrolysis). Particularly, butylparaben and ben-
zylparaben shift the steady-state inactivation curve 2- and 3-times more than propylparaben, respectively.
Parabens are blockers of hNaV1.2 channels, sharing the mechanism of action of most of sodium channel blocking
antiseizure drugs. The potency of this inhibition increases with the size of the lipophilic alcoholic residue of the
ester group. These results provide a basis for rational drug design directed to generate new potential antic-
onvulsant agents.
1. Introduction
Epilepsy is a chronic neurological disorder that affects more than 50
million people worldwide. It is characterized by different levels of
neuronal hyperexcitability producing recurrent seizures. Despite the
wide diversity of available antiepileptic drugs (AEDs), there is still a
high percentage (close to 30%) of therapeutic failure, caused by the
lack of efficacy of available drugs to control seizures; furthermore, the
occurrence of side effects frequently leads to treatment suspension
[1,2]. This situation raises the need to find new compounds capable of
controlling epilepsy, with improved efficacy and tolerability.
The pharmacological treatment of epilepsy involves, for most AEDs,
the prevention of seizure onset and propagation by inhibition of neu-
ronal hyperexcitability. An established anticonvulsant mechanism in-
volves the inhibition of voltage-operated Na+ channels (NaV) expressed
in the central nervous system (particularly the isoforms NaV 1.1, NaV
1.2, NaV 1.3, and NaV 1.6) which have a key role in the initiation and
propagation of neural action potential discharge [3–5] Particularly,
AEDs such as phenytoin, carbamazepine, lamotrigine, oxcarbazepine,
eslicarbazepine, zonisamide, and lacosamide exert their pharmacolo-
gical effect by a state-dependent inhibition of neuronal NaV channels
due to their higher affinity for the open and inactivated channel states
[6]. Moreover, interaction with these drugs stabilizes the channel in the
inactivated state, making difficult their transition to the closed resting
state and consequently reducing the action potential discharge and
neuronal excitability [7].
Parabens are a homologous series of esters of p-hydroxybenzoic acid
(including methyl, ethyl, propyl, butyl, and benzyl paraben, among
others), used singly or in combination as antimicrobial preservatives in
foods, drugs, and cosmetics for over 50 years. They are safe to use (i.e.
relatively non-irritating, non-sensitizing, and low- toxic) and there have
been several safety assessments on these substances by a diversity of
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agencies, including FAO/WHO, FDA and FEMA [8–10].
In a previous work, Talevi and col. (2007) reported that pro-
pylparaben (PPB) and methylparaben (MPB) elicited anticonvulsant
effects in the Maximal Electroshock Seizure (MES) test in mice [11].
Later, it was shown that PPB blocks the NaVcurrents in rat brain slices
and prevents the 4AP-induced epileptogenic discharges of hippocampus
CA1 pyramidal neurons [12]. Besides, PPB also showed anticonvulsant
effects against pilocarpine-induced seizures and reduced the neuronal
damage and the excitability produced by status epilepticus and spon-
taneous recurrent seizures in rats [13].
The anticonvulsant effect of PPB in rodents, together with the va-
luable information about its safety and pharmacokinetics and their
versatile chemistry, makes the parabens interesting candidates to in-
vestigate possible therapeutic applications as well as their mechanism
of action. Here, using the patch-clamp technique, we fully characterized
the mechanism of action of PPB on human NaV 1.2 channels (hNaV 1.2)
expressed in HEK293 cells. Besides, we tested the effect of the other p-
hydroxybenzoic acid esters of the series: MPB, ethylparaben (EtPB),
butylparaben (BuPB) and benzylparaben (BePB), for a preliminary in-
sight on a structure-activity relationship for this class of compounds.
Finally, p-hydroxybenzoic acid, the major metabolite of parabens, was
also investigated.
2. Materials and methods
2.1. Cell culture
All experiments were performed in HEK293 cells stably expressing
hNaV1.2 α-subunits (a kind gift of GlaxoSmithKline, Stevenage, UK)
that have previously been described [14–16] and used in our lab
[17,18]. HEK293 cells were cultured in minimum essential medium
(DMEM HIGH), containing 10% fetal bovine serum, and 0.5% geneticin
G418 sulfate, in a 5% CO2 atmosphere at 37 °C.
2.2. Whole-cell voltage-clamp recordings
The cells were detached from the culture flask and settled in a glass-
bottom experimental chamber with 3 mL extracellular solution con-
taining (in mM): NaCl 50, N-methyl-D-glucamine 90, CaCl2 2, MgCl2 1,
HEPES 10 and glucose 11; pH was adjusted to 7.4 with HCl. The patch
electrodes were filled with pipette solution containing (in mM): CsF
100,CsCl 40, EGTA 10, HEPES 10, NaCl 5, MgCl2 2; Na2ATP 4; the pH
was adjusted to 7.3 with CsOH. Cells were observed with a mechani-
cally stabilized inverted microscope (Telaval 3, Carl Zeiss, Jena,
Germany) equipped with a 40X objective lens. The test solutions were
applied through a multi-barreled pipette, by gravity and in continuous
flux, positioned close to the target cell. After each experiment on a
single cell, the experimental chamber was replaced by another one
containing a new sample of cells. All experiments were performed at
room temperature (∼ 22 °C). The standard tight-seal whole-cell con-
figuration of the patch-clamp technique was used to record macroscopic
currents [19]. Glass pipettes were drawn from GB150T-10 glass on a
microprocessor-controlled vertical pipette puller (PUL-100, World
Precision Instrument, Sarasota, FL. USA) and pipette resistance ranged
from 2 to 3 MΩ. Voltage-clamp protocols were applied by the com-
puter-controlled Axopatch 200A amplifier (Axon Instruments, Mole-
cular Devices, Sunnyvale, CA, USA). Currents were filtered with a 4-
pole lowpass Bessel filter at 2 kHz and digitized (Digidata 1440, Mo-
lecular devices) at a sampling frequency of 200 kHz. Compensation
circuitry was used to reduce the series resistance error by at least 80%.
The currents were corrected offline for linear nonspecific leak and re-
sidual capacitive current. The experimental recordings were stored on a
computer hard disk for later analysis.
NaV current amplitude and series resistance stability were evaluated
with a 15 ms-voltage-clamp step from a holding potential of − 80 mV
to a test potential of − 20 mV repeated each 10 s. The time needed for
the current stabilization was variable. Once the stability was achieved,
the same voltage protocols (see below) were applied in the control
conditions (vehicle) and in the presence of parabens, dissolved in 0.1%
dimethylsulfoxide. Each protocol was performed at least twice in each
extracellular solution to check stability.
Fig. 1. PPB induces a left-shift in steady-state inactivation curves of
hNaV1.2 channels in a concentration-dependent manner. A) Superimposed
typical traces of the hNaV1.2 channel mediated currents obtained in HEK293
cells at the test pulse of the steady-state inactivation curves (protocol given as
inset), before and after 100 μM PPB perfusion. B) Mean steady-state inactiva-
tion curves obtained from recordings at different PPB concentrations. The
available fraction was calculated as the peak current observed on each test
pulse normalized by the one corresponding to the −130 mV pre-conditioning
pulse (I/Imax). Solid lines represent the fit of the points of each condition with
a Boltzmann equation. C) Mean V1/2 displacement values at different PPB
concentrations. The comparison with the control was made using one-sample t-
test against a hypothetical value of zero. To compare different concentrations of
PPB one-way ANOVA was used followed by a post hoc Tukey´s multiple com-
parisons test. (N = 3-6).
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2.3. Voltage-clamp protocols
The effect of parabens on the inactivated state of hNaV1.2 channels
was evaluated by using a typical double voltage step protocol. From a
resting potential of -80 mV, we applied a series of pre-conditioning
steps during 2500 ms (from -130 to −40 mV), each followed by a test
pulse of 25 ms to −10 mV. The magnitude of peak current evoked by
the test pulse to −10 mV depends on the available channels to be
opened after each pre-conditioning pulse. The available fraction at each
potential was calculated as the relationship between the peak current
measured in the test pulse preceded by each pre-conditioning step (I)
and the one evoked after a pulse of −130 mV where in our recordings
the current was the maximal (Imax). Then, plotting the available
fraction (I/Imax) against the voltage of the pre-conditioning voltage
step, allows obtaining the h curve which was fitted with the Boltzmann
equation to obtain the V1/2 (the potential of half-maximal inactivation)















The ability of parabens to modify the time required for channel
recovery from the inactivated state, was tested by using a double-pulse
protocol where two depolarizing voltage steps from −80 mV to −20
mV were applied separated by a variable time interval at −80 mV
(from 0.5–48 ms), during which the current was allowed to recover
from the inactivation induced by the first voltage step. Then, the ratio
between the peak current values of the second pulse and the one cor-
responding to the first pulse was plotted against the time between the
two pulses. The points were fitted with an exponential function (Eq. 2)
Fig. 2. Voltage-dependence of PPB-induced hNaV1.2 channel inhibition. PPB concentration-response curves of hNaV1.2 channel mediated current inhibition to
pre-conditioning pulses of −130 mV, −90 mV, −80 mV, −70 mV and −60 mV. (N = 3-6). Solid lines represent the fit of the points of each condition with a Hill
equation. Bar graph represents the IC50 values obtained from curves adjustments corresponding to mentioned above pre-conditioning potentials.
Fig. 3. PPB increases the hNaV1.2 channel
time for recovery from inactivation. A)
Superimposed typical traces of the hNaV1.2
channel mediated currents obtained from the
double-pulse protocol before and after 100 μM
PPB perfusion. B) Current ratio between the
second and the first pulse as a function of the
time elapsed between them for one of the ty-
pical cells. Solid lines represent the fit of the
points of each condition with an exponential
relationship. C) Mean time constant values (τ)
obtained for control and 100 μM PPB group.
Paired t-test (N = 3).
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to obtain the temporal parameter of the NaV channels recovery from








where I2°/I1° represents the available fraction of recovered channels
and τ is the time constant of this process.
The frequency-dependent block of parabenswas studied applying 20
identical voltage pulses of 3 ms at −10 mV, from a holding potential of
-80 mV, at a constant frequency (10 Hz, 25 Hz and 50 Hz). The ratio
between the peak current values (I )x evoked by each pulse with the one
corresponding to the first pulse (I )1º was plotted against the number of
pulse. The frequency dependence was measured as a reduction in the
ratio of current values at the 20th pulse when the tested frequency
increases.
Furthermore, the data obtained from h curves were also useful to
analyze if parabens were able to bind to the closed channel state. When
the pre-conditioning applied potential was −130 mV the closed
channel state fraction was maximal in all conditions evaluated, so, we
measured the magnitude of NaV peak current occurring at the corre-
sponding test pulse (I control) in control condition, and after incubation
Fig. 4. PPB promoted a frequency-dependent inhibition on hNaV1.2 channels. A) Typical traces of the hNaV1.2 channel mediated currents evoked by a train
voltage pulses before and after 100 μM PPB perfusion. B) Mean current ratio between each pulse and the first pulse vs. pulse number (N = 7). The inset graphs
represent the recordings of the first and the last pulses obtained in the presence of 100 μM PPB. C) Mean current ratio between the last and the first pulse obtained at
frequency of 10 Hz, 25 Hz and 50 Hz. The asterisk means that currents are significantly affected stimulatory frequency and PPB (two-way ANOVA, N= 7, Bonferroni
post-test).
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of 1−5 min with the drug. The ratio of these magnitudes allow us to






Also, using the data from h curves, we constructed the concentra-
tion-response curves of the inhibitory effect of PPB and BePB on hNaV
1.2 currents elicited at −10 mV, after the pre-conditioning pulses of
−130 mV, −90, −80, −70 or −60 mV. Then, the relationships were





1 10 IC X Hill Slope[(log ) ]50 (4)
where X is the concentration if the tested paraben. As we defined above,
the curve corresponding to the pre-conditioning pulse of −130 mV
represents the concentration dependence of the closed state block,
while the remaining curves show addition of the voltage-dependent and
-independent inhibition.
2.4. Data and statistical analysis
Statistical analyses were carried out using GraphPad Prism version
7.00 for Windows (GraphPad Software, La Jolla California USA, www.
graphpad.com). Data are given as the mean± SEM. Multiple groups
were compared using a one-way or two-way ANOVA followed by a post
hocTukey´s and Bonferroni tests, respectively for multiple comparisons
test. Paired Student’s t-test was used for the direct comparison of two
conditions. Statistical significance of the change in the V1/2 parameter
induced by parabens was tested by one-sample t-test against a hy-
pothetical value of zero.Statistical significance of percentage of closed
channel blockage was tested by one-sample t-test against a hypothetical
value of 1. P<0.05 was considered to indicate a significant difference.
2.5. Materials
PPB (Parafarm, Bs As, Argentina) and BePB (Merck, Darmstast,
Germany) were dissolved in DMSO (Merck, Darmstast, Germany) to
make stock solutions of 3, 10, 30, 60, 100, 300 and 1000 mM. EtPB
(Merck, Darmstast, Germany), MPB (Parafarm, Bs As, Argentina), BuPB
(Merck, Darmstast, Germany),) and p-hydroxybenzoic acid (Fluka)
were dissolved in DMSO to make a stock solution of 100 mM. An ap-
propriate amount of DMSO was added to all control solutions.
3. Results
3.1. Inhibitory effect of PPB on hNaV1.2 channels
We first evaluated the ability of PPB to block hNaV1.2 channels in a
state-dependent manner by applying the double voltage step protocol
described in the Materials and Methods section. In Fig. 1 (B and C) are
depicted the data showing that PBB induces a significant left-shift of the
h curve, quantified by the change in the V1/2 measured for each cell,
before and after a stable effect of PPB at different concentration (ΔV1/
2). This effect suggests that PBB in a concentration-dependent way can
bind to the inactivated state of hNav1.2 channels and stabilize this
conformation. Moreover, is possible to observe in Fig. 1B that, after the
pre-conditioning potential of −130 mV the available fraction of
hNaV1.2 channels (at the closed state) was maximal at all tested PPB
concentrations. However, the current amplitude in the test pulse is
visibly reduced when compared with the magnitude of the control
current evoked after the same pre-conditioning potential (Fig. 1A). This
fact can be explained by considering that PBB, not only blocks the in-
activated state of the channel, like the left shift of h curve demonstrates,
but also it is able to block the closed state of the hNa1.2v channel de-
creasing the number of channels available to open during the test po-
tential.
After this analysis, we can observe that PBB is able to inhibit both,
the closed and the inactivated state of Nav1.2 channels. Thus, we
perform additional analysis to evaluate the weight of the two compo-
nents in the global inhibitory effect, which is presented in Fig. 2, where
the percentage of PBB blocking effect on Na + current magnitude
(evoked by the test pulse after different preconditioning potentials) was
plotted versus PBB concentration. Then, the relationships were fitted
with Eq.4. Particularly, the IC50 obtained at the preconditioning pulse
of −130 mV exclusively depends on the binding of PPB to the Nav1.2
channels closed state. However, we observed an increase in drug affi-
nity (a reduction in the obtained IC50s) when the pre-conditioning
potential was more depolarized and the proportion of channels at the
inactivated state increases. This result suggests that PPB affinity for the
inactivated state is higher respect for the closed state, which is clearly
evident at lower concentrations (e.g.: 10 and 30 μM) where the in-
hibitory effect at the closed state (−130 mV of preconditioning pulse)
is null, but there is a clearly blocking at preconditioning potentials
where the channels can adopt the inactivated states.
3.2. hNaV 1.2 channel recovery from fast inactivation is delayed by PPB
To evaluate the effect of PPB on hNaV 1.2 channel recovery from
fast inactivation, we performed a standard protocol where two depo-
larizing steps (to -20 mV) separated by a variable recovery time at -80
mV was applied before and after 100 μM PPB perfusion (Fig. 3). The
temporal course of the recovery from inactivation state is shown in
Fig. 3B for both conditions, where it is possible to observe that PPB
significantly increases the rate constant of the process (τ: 35.1± 3.2 ms
for PPB vs 6.6±0.3 ms for the control group). This result indicates that
hNaV1.2 channels in the presence of PPB need more time to recover
from the inactivated state, which is consistent with the stabilizing effect
induced by PPB and evidenced before (Fig. 1).
3.3. Frequency-dependent blockage induced by PPB
Most of the AEDs that bind to the inactivated state of the NaV
channels and prolong the time of recovery from fast inactivation are
able to promote a frequency-dependent blocking effect. We evaluated if
PPB shares this property by measuring the hNaV1.2 current activated by
a train of 3 ms depolarizing steps, at either 10, 25, and 50 Hz, in control
conditions and the presence of 100 μM PPB. As shown in a typical
hNaV1.2 current recording performed at different frequencies of pulse
stimulation (Fig. 4A), already in the control condition, is possible to
observe that the magnitude of peak currents shows a decay during
pulsing, and this is increased in the presence of 100 μM PPB (Fig. 4 B).
The effect was frequency-dependent since the same number of test
pulses induced a significant higher block when applied at frequencies of
25 and 50 Hz (Fig. 4C). These results reinforce the idea that PPB, likely
by inducing stabilization of hNaV1.2 channel inactivated state, can re-
duce the resting state available fraction of channels that could be ac-
tivated by a second depolarizing stimulus when cells are exposed at a
Table 1
Effect of 100 μM parabens on NaV1.2 peak current evoked at -20 mV from a
holding potential of -80 mV. The inhibitory effect was statistically significant
for all tested parabens (paired t-test). Additionally, one way ANOVA (on
Tukey’s) was used to compare the level of inhibition between the different
parabens: * represents differences respect to MPB, while + respect to EtPB, @
respect to PPB and # respect to BuPB.
Paraben (100 μM) blocking percentage SEM N
MPB 11.4 1.0 4
EtPB 15.0 2.9 3
PPB 39.7* 6.2 6
BuPB 72.2*+@ 6.3 6
BePB 93.8*+@# 3.4 5
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high frequency of stimulation.
3.4. Comparison of PPB effects with MPB, EtPB, BuPB, and BePB on hNaV
1.2 channels
The first screening of the series of parabens showed that all of them,
tested at 100 μM, inhibited hNaV 1.2 channels, which was evidenced by
a reduction of peak Na+ current measured at -20 mV from a holding
potential of -80 mV (Table 1). These values show that the inhibitory
effect increases with the lipophilicity of the residue in the ester
function. So, we explored if all of these parabens share the blocking
mechanisms observed for PPB. We probed that BuPB and BePB pro-
duced a significant left-shift in the h curves (Fig. 5A-C) and a reduction
in the Na+ current evoked after the pre-conditioning pulse of−130 mV
(Fig. 5D). The last effect was also observed for EtPB. And again, both
properties increased with the lipophilicity of the ester function.
Then, we tested the frequency-dependent inhibition of the complete
paraben series. In this case, only the 50 Hz train pulse was used and
each paraben was tested at a concentration of 100 μM, except for BePB,
which was tested at 30 μM since, at 100 μM, it achieves and immediate
Fig. 5. Parabens inhibitory effect on hNaV1.2 channels is both voltage-dependent and independent. A) Superimposed typical traces of the hNaV1.2 channel
mediated currents obtained at the test pulse of the steady-state inactivation protocol before and after 100 μM MPB, EtPB, PPB, BuPB or BePB perfusion. B) Mean
steady-state inactivation curves obtained from recordings with the tested parabens. The available fraction was calculated as the peak current observed on each test
pulse normalized by the one corresponding to the −130 mV pre-conditioning pulse (I/Imax). Solid lines represent the fit of the points of each condition with a
Boltzmann equation. C) Mean V1/2 displacement values. The comparison with the control was made using one-sample t-test against (vs 0). To compare the effect of
BuPB and BePB respect to PPB, one-way ANOVA was used followed by a post hoc Tukey´s multiple comparisons test. D) Mean values of parabens closed state block
calculated as the inhibition in the current evoked after a pre-conditioning pulse of −130 mV. The comparison with the control was made using one-sample t-test
against (vs 1). To compare the effect of different parabens, one-way ANOVA was used followed by a post hoc Tukey´s multiple comparisons test.
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and full inhibition (data not shown). The obtained results presented in
Fig. 6 and Table 2, where it can be observed that, except for MPB, all
compounds significantly produce a frequency-dependent blockage as
PBB do.
3.5. Characterization of BePB inhibition of hNaV1.2 channels
As clearly show our results, the benzyl group (Be) confers the major
potency of all parabens tested. Then, we fully characterized the elec-
trophysiological profile of BePB blockage on hNaV1.2 channels.
First, we analyzed the concentration-dependence of BePB hNaV1.2
current inhibition. This paraben, in a concentration-dependent manner,
Fig. 6. Frequency-dependent blockage of hNaV1.2 channels by parabens. A) Typical traces of the hNaV1.2 channel mediated currents evoked by a train voltage
pulses before and after MPB, EtPB, PPB, BuPB and BePB perfusion. B) Mean current ratio between each pulse and the first pulse vs. pulse number (N = 3-6).
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significantly changed the V1/2 toward a more hyperpolarized mem-
brane potential (Fig. 7). Moreover, and in the same way as PBB, for
BePB the IC50 is reduced when preconditioning pulses are more depo-
larized (Fig. 8).
Regarding the recovery time from the fast inactivation state, BePB
delayed the recovery kinetic since the time constant value (τ) was
significantly higher respect to the control value (Fig. 9). Finally, we
demonstrated that 30 μM BePB blocks the channels in a frequency-de-
pendent manner, which was evident at 25 and 50 Hz while it did not
affect the Na+ current decay when it was stimulated at a 10 Hz fre-
quency (Fig. 10).
3.6. p-hydroxybenzoic acid effect on hNaV1.2 channel mediated currents
As a final point, and considering that p-hydroxybenzoic acid (PHBA)
is the major metabolite from parabens, resulting from the ester function
hydrolysis [20,21], we also tested its effect on hNaV1.2 currents evoked
by the steady-state inactivation protocol. Interestingly, 100 μM PHBA
produced a significant left-shift of the hNaV1.2 h curve (ΔV1/2 =
2.4±0.6) suggesting that it is able to stabilize the inactivated state of
hNaV1.2 channels (Fig. 11A-C). However, p-hydroxybenzoic did not
produce a significant blockage of closed state channels as the other
parabens did (Imax p-hydroxybenzoic acid/ Imax control = 0.9± 0.1;
one-sample t-test vs. 1. N = 5) (Fig. 11D). The PHBA effect was mild
when compared with the ones observed for PPB and the more potent
parabens such as BuPB and BePB.
4. Discussion
In the present study, a preliminary structure-activity relationship of
a series of parabens as hNav1.2 channel inhibitors was established, and
characterized the electrophysiological properties of their mechanism of
action. First, we show that PBB, a common preservative, and the first
paraben described as a NaV channel inhibitor with anticonvulsant
properties [11–13] is able to inhibit the hNav1.2 channel isoform in a
state-dependent manner. Then, we demonstrated that hydrophobicity
of the residue at the ester group is determinant in the potency for the
channel block, being the BePB the most potent among the parabens
tested. So, here appeared a new promising compound sharing the
blocking profile mechanism of several AEDs, which modulates Nav
channels [16,22,23].
Nav channels blockers are commonly used in the clinic as anti-
epileptic, antiarrhythmic, and anesthetics. Despite these drugs share a
common binding domain in the pore of the channel, they differ in the
affinity for the different conformational states that the drugs can sta-
bilize. The ability of Nav channel inhibitors to discriminate between
states (closed, open, and inactivated) was early described by B. Hille
and known as the “modulated receptor hypothesis” which shows as
they promote different blocking profiles well correlate with the clinical
utility of Nav channels inhibitors [24,25]. Here, we demonstrated that
PPB and BePB, as reference compounds of the paraben series, inhibit
hNav1.2 channel by a mechanism that presents a major activity on the
inactivated state of the channel. We demonstrated that PPB and BePB
can stabilize the inactivated state of hNav1.2 channel because of in
presence of these compounds, more negative membrane potentials are
necessary to have the same available hNav1.2 fraction than in control
condition (Figs. 1 and 7), and a longer time is needed to recover the
channels from the fast reached inactivated stated (Figs. 3 and 9).
However, our data also showed an inhibitory effect on the closed state
of the channels, which was visible as the Na+ current reduction when
the cell was preconditioned with very negative membrane potential
(−130 mV) where the proportion of channels in the inactivated state is
Table 2
Parabens frequency-dependent block. I20/I1 represents the fraction of current
recorded in 20th pulse respect current recorded in the first pulse. * indicates
that differences are statistically significant (Paired t-test).
Paraben Condition I20/I1(mean± SEM) N
100 μM MPB control 0.54± 0.05 4
MPB 0.41± 0.09
100 μM EtPB control 0.77± 0.01 3
EtPB 0.70± 0.02*
100 μM PPB control 0.78± 0.05 6
PPB 0.39± 0.03*
100μM BuPB control 0.73± 0.05 6
BuPB 0.40± 0.05*
30 μM BePB control 0.74± 0.06 5
BePB 0.47± 0.04*
Fig. 7. BePB induces a left-shift in steady-state inactivation curves of
hNaV1.2 channels in a concentration-dependent manner. A) Superimposed
typical traces of the hNaV1.2 channel mediated currents obtained at the test
pulse of the steady-state inactivation curves (protocol given as inset), before
and after 100 μM BePB perfusion. B) Mean steady-state inactivation curves
obtained from recordings at different BePB concentrations. The available frac-
tion was calculated as the peak current observed on each test pulse normalized
by the one corresponding to the −130 mV pre-conditioning pulse (I/Imax).
Solid lines represent the fit of the points of each condition with a Boltzmann
equation. C) Mean V1/2 displacement values at different BePB concentrations.
The comparison with the control was made using one-sample t-test against a
hypothetical value of zero. To compare different concentrations of BePB one-
way ANOVA was used followed by a post hoc Tukey´s multiple comparisons
test. (N = 3-6).
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null (Fig. 1 and 7). However, a higher affinity of these parabens for the
hNav1.2 channel inactivated state, respect to the closed state, was ob-
served as a lower IC50 of channel inhibition obtained when depolarized
membrane potential promotes an increase in the numbers of channels in
the inactivated state.
On the other hand, when the activity of Nav channels is induced by
a repetitive stimulation, most of Nav channels blockers can promote a
Na+ current reduction, by different mechanisms. The open channel
blockers require the opening of channels to allow the drug binding to a
channel domain accessible only is the channel reaches the open state.
Thus, under repetitive stimulation, there is an additive channel
blockage at each pulse of the train stimulation, since more channels are
passing through the open conformation. This blocking mechanism,
called use-dependent block, depends on the number of channels that
adopt the open conformation and it is low influenced by the time oc-
curred between each pulse, in other words, the frequency of the pulse
train. In contrast, if the time between two stimuli is short (higher sti-
mulation frequencies), drugs that delay the recovery from the
inactivated state reduces the available fraction of Nav channels to be
opened at the next pulse. This reduction in the available fraction is
additive in subsequent pulses and increases whit the frequency of sti-
mulation [24,25]. Here, we demonstrate that the hNav1.2 channel
block by PPB and BePB is frequency-dependent (Figs. 4 and 10) con-
firming their preference for the inactivated state of the channel.
These properties of the state-dependent block directed to the in-
activated state is a common feature of AEDs that target Nav channels
because it confers some advantages as achieving a selective effect on
depolarized neurons, and therefore hyperexcitable, that participate in
the epileptic focus [4,23–25]and became important to diminish the
activity in neurons with higher frequencies of firing. Therefore, we can
hypothesize that neurons involved in seizure propagation presenting
higher firing frequencies[4] would be more susceptible to the NaV
channel inhibition induced by parabens, and neurons that are not
participating in seizure initiation and/or propagation would be less
affected. This fact makes parabens interesting candidates also in terms
of reducing possible adverse effects related to their effects on well-
Fig. 8. Voltage-dependence of BePB-induced hNaV1.2 channel inhibition. BePB concentration-response curves of hNaV1.2 current inhibition to pre-conditioning
pulses of −130 mV, −90 mV, -80 mV, −70 mV and −60 mV. (N = 3-6). Solid lines represent the fit of the points of each condition with a Hill equation. Bar graph
represents the IC50 values obtained from curves adjustments corresponding to mentioned above pre-conditioning potentials.
Fig. 9. BePB increases the hNaV1.2 channel
time for recovery from inactivation. A)
Superimposed typical traces of the hNaV1.2
channel mediated currents obtained from the
double-pulse protocol before and after 30 μM
BePB perfusion. B) Current ratio between the
second and the first pulse as a function of the
time elapsed between them for one of the ty-
pical cells. Solid lines represent the fit of the
points of each condition with an exponential
relationship. C) Mean time constant values (τ)
obtained for control and 100 μM BePB group.
Paired t-test (N = 6).
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functioning neurons.
The ability of Nav channels blockers to discriminate between states
is related to the facility to access to their common binding site. Open
channel blockers are mostly hydrophilic and require an aqueous
pathway that appears with the opening of the intracellular activation
gate, which is tightly closed. In contrast, small hydrophobic drugs can
access the binding site from the lipid membrane using fenestrations
sideways into the drug receptor site without requiring channel opening
[24,26]. The latter mechanism could be an explanation for the in-
creased parabens activity with the hydrophobicity of the residue at the
ester function (Figs. 5 and 6). Particularly, the potency in state-de-
pendent inhibition of BePB was three-times higher, than PPB, so they
are expected to present a higher in vivo activity. Knowing the protec-
tive effects of PPB in mice [11] and rats [13], it is expected that BePB
will present a higher anticonvulsant effect in vivo.
We also demonstrated that the main metabolite of parabens, the p-
hydroxybenzoic acid shared the state-dependent inhibitory effect with
their esterified analogous. Although its potency was much lower com-
pared with parabens, it could contribute to their anticonvulsant ac-
tivity, exerting a residual effect after the metabolism of parabens, and
so extending the time of the anticonvulsant in vivo effect.
Parabens safety and pharmacokinetics have been extensively stu-
died in a diversity of animal species and clinical studies, including
acute, sub-chronic and chronic toxicity assessment, carcinogenesis,
Fig. 10. BePB promoted a use-dependent inhibition on hNaV1.2 channels A) Typical traces of the hNaV1.2 channel mediated currents evoked by a train voltage
pulses before and after 30 μM BePB perfusion. B) Mean current ratio between each pulse and the first pulse vs. pulse number (N=5-7). The inset graphs represent the
recordings of the first and the last pulses obtained in the presence of 30 μM BePB. C) Mean current ratio between the last and the first pulse obtained at frequency of
10 Hz, 25 Hz and 50 Hz. The asterisk means that currents are significantly affected stimulatory frequency and BePB (two-way ANOVA, N=5-7, Bonferroni post-test).
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teratogenesis, and genotoxicity studies, among others [27,28]. Un-
fortunately, most of the studies were done in vivo, which difficult a
direct comparison with the concentrations needed to obtain hNav 1.2
block in vitro and with a human protein. However, the PPB dose needed
for its anticonvulsant activity in mice (30, 100, and 300 mg/kg) is
below the toxic doses reported in this species (> 8 g/kg)[11,27]. In
contrast, considerable controversy has risen in the last decades around
the endocrine-disrupting/estrogenic and androgenic potential of para-
bens [29], which led different regulatory agencies around the world to
limit concentrations of PPB and BuPB in cosmetic and other products. In
vitro studies in human cells are needed to compare with those reported
here to inhibit hNaV1.2 channels, future studies should focus on the
development of parabens analogs/derivatives with no endocrine dis-
ruption potential.
5. Conclusions
Our results describe the molecular mechanism of action of the PPB
as a hNaV1.2 channel blocker, and show that, with a higher potency,
other parabens including butyl and benzyl esters share this desirable
characteristic for AEDs. These facts, together with the anticonvulsant
and neuroprotective activities of PPB reported in previous studies,
allow us to postulate parabens repositioning for the treatment of epi-
lepsy. Moreover, our findings put in evidence like the lipophilicity of
the ester group is a relevant structural requirement to increase parabens
ability to inhibit the hNaV1.2 channel, representing a promising starting
point for the design of more potent paraben analogs.
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